Literature DB >> 23271279

Implication of receptor activator of NF-κB ligand in Wnt/β-catenin pathway promoting osteoblast-like cell differentiation.

Bin Nie1, Shaoqiong Zhou1, Xin Fang1, Wei Li1, Bin Wang1, Siming Guan2.   

Abstract

Recent studies showed that activation of Wnt/β-catenin pathway promoted the differentiation of osteoblast-like cells in the arterial calcification, but its mechanism remains unknown. In this study, the hypothesis that Wnt/β-catenin pathway promotes the differentiation of osteoblast-like cells by upregulating the expression of receptor activator of NF-κB ligand (RANKL) was examined. LiCl was used to activate the Wnt/β-catenin pathway. The differentiation of osteoblast-like cells was observed by Von Kossa staining, calcium content assay, alkaline phosphatase (ALP) activity assay, and detection of osteocalcin expression. Real-time PCR was performed to detect the expression of RANKL and osteoprotegerin (OPG, the decoy receptor of RANKL) during the osteoblast-like cell differentiation. Different concentrations of OPG were added to the culture media respectively to inhibit the function of RANKL, and the change in the differentiation of osteoblast-like cells was evaluated. The results showed that when the Wnt/β-catenin pathway was activated by LiCl, the expression of RANKL was significantly increased, which coincided with the differentiation of osteoblast-like cells (P<0.05), and the OPG treatment could partly attenuate the promoting effect of Wnt/β-catenin pathway on the differentiation of osteoblast-like cells (P<0.05), but it failed to completely abolish such effect. It was concluded that activation of Wnt/β-catenin pathway promotes the differentiation of osteoblast-like cells by both RANKL-dependent and RANKL-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271279     DOI: 10.1007/s11596-012-1040-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

1.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

2.  Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.

Authors:  Hui Xie; Ping-Li Xie; Xian-Ping Wu; San-Mei Chen; Hou-De Zhou; Ling-Qing Yuan; Zhi-Feng Sheng; Si-Yuan Tang; Xiang-Hang Luo; Er-Yuan Liao
Journal:  Cardiovasc Res       Date:  2011-07-12       Impact factor: 10.787

3.  Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin.

Authors:  Ping Olesen; Kirsten Nguyen; Lise Wogensen; Thomas Ledet; Lars Melholt Rasmussen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-20       Impact factor: 4.733

Review 4.  Cell biological and physicochemical aspects of arterial calcification.

Authors:  Ellen Neven; Tineke M De Schutter; Marc E De Broe; Patrick C D'Haese
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

Review 5.  Molecular mechanisms of vascular calcification: lessons learned from the aorta.

Authors:  Jian-Su Shao; Jun Cai; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-06       Impact factor: 8.311

6.  Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.

Authors:  Susann Helas; Claudia Goettsch; Michael Schoppet; Ute Zeitz; Ute Hempel; Henning Morawietz; Paul J Kostenuik; Reinhold G Erben; Lorenz C Hofbauer
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

Review 7.  Osteogenic regulation of vascular calcification: an early perspective.

Authors:  Radhika Vattikuti; Dwight A Towler
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05       Impact factor: 4.310

8.  Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

Authors:  J J Castellot; L V Favreau; M J Karnovsky; R D Rosenberg
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

Review 9.  Vascular calcification: mechanisms and clinical ramifications.

Authors:  Moeen Abedin; Yin Tintut; Linda L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-20       Impact factor: 8.311

10.  Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.

Authors:  Belinda A Di Bartolo; Michael Schoppet; Muhammad Z Mattar; Tilman D Rachner; Catherine M Shanahan; Mary M Kavurma
Journal:  Cardiovasc Res       Date:  2011-03-29       Impact factor: 10.787

View more
  3 in total

Review 1.  Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation.

Authors:  Aaron W James
Journal:  Scientifica (Cairo)       Date:  2013-12-12

2.  Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway.

Authors:  Shaoqiong Zhou; Xin Fang; Xing Fang; Huaping Xin; Wei Li; Hongyu Qiu; Siming Guan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

3.  Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A.

Authors:  Jian Cheng; Hai-Yan Xu; Ming-Ming Liu; Jian-Ping Cai; Lei Wang; Zhen Hua; Xiao-Dong Wu; Wei-Ling Huo; Nan-Ning Lv
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-13       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.